NCT04483323

Brief Summary

To improve the outcome after surgery, effective pain control is needed. The aim of the current study was to compare the efficacy of ultrasound guided erector spinae plane block versus the intra articular injection of local anesthetic for post-operative analgesia in patients undergoing shoulder arthroscopy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2020

Completed
9 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2021

Completed
Last Updated

April 6, 2021

Status Verified

April 1, 2021

Enrollment Period

8 months

First QC Date

July 20, 2020

Last Update Submit

April 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The amount of total postoperative rescue analgesic consumption (mg)

    Rescue analgesia in the form of diclofenac sodium 75mg intramuscularly (IM) will be given if the visual analogue scale ≥ 40

    First 24 hours postoperative

Secondary Outcomes (1)

  • Postoperative visual analogue scale

    First 24 hours postoperative

Other Outcomes (1)

  • The time to first request of rescue analgesia (hours)

    First 24 hours postoperative

Study Arms (2)

Group I: Intraarticular group ( IA )

ACTIVE COMPARATOR

Patients will receive 20 ml of 0.25% bupivacaine intra-articularly through the surgical port

Procedure: Intraarticular Injection

Group II: Erector Spinae Plane Block group ( ES )

EXPERIMENTAL

Patients will receive an ultrasound guided erector spinae plane block using 20 ml of 0.25% bupivacaine at the level of T2 transverse process

Procedure: Erector Spinae Plane Block

Interventions

The patient will be placed in the lateral position. Following skin disinfection, counting down from the C7 spinous process and using ultrasound guidance, the level of T2 transverse process will be identified. A 2-5 MH2 curved array transducer (sono site Edge, Bothell, Will behington) will be positioned transversely to visualize the lateral tip of T2 transverse Process. A longitudinal parasagittal orientation will be obtained over the transverse process using a 22 - gauge 8 cm block needle (visioplex, Vygon , France) will be inserted in plane to US beam in a caudal to cranial direction to place the needle tip between the posterior fascia of the erector spinae muscle and the T2 transverse process. Position of the needle tip in the ESP deep to the erector spinae muscle will be confirmed using hydrodissection with 0.5 - 1 ml of normal saline and visualization of the linear fluid spread deep to the erector spinae muscle following which 20 ml of 0.25% bupivacaine will be injected.

Group II: Erector Spinae Plane Block group ( ES )

Intraarticular injection of local anesthetic through the surgical port

Group I: Intraarticular group ( IA )

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I-II
  • Posted for elective shoulder arthroscopy

You may not qualify if:

  • Coagulopathy
  • Allergy to local anesthetics
  • Chronic use of narcotics
  • Necessity for an intra articular drain after surgery
  • Patients refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University Hospitals

Tanta, ElGharbiaa, 31527, Egypt

Location

MeSH Terms

Interventions

Injections, Intra-Articular

Intervention Hierarchy (Ancestors)

InjectionsDrug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Taysser M Abdelraheem, MD

    Lecturer at Tanta University Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Study Record Dates

First Submitted

July 20, 2020

First Posted

July 23, 2020

Study Start

August 1, 2020

Primary Completion

March 15, 2021

Study Completion

March 16, 2021

Last Updated

April 6, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations